"Designing Growth Strategies is in our DNA"

U.S. Human Insulin Market Size, Share & COVID-19 Impact Analysis, By Type (Analog Insulin and Traditional Insulin), By Diabetes Type (Diabetes 1 and Diabetes 2), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2023-2030

Last Updated: January 20, 2025 | Format: PDF | Report ID: FBI107469

 


To get information on various segments, share your queries with us

  ATTRIBUTE

  DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate  

CAGR of 1.3% from 2023-2030

Unit

Value (USD Billion)

Segmentation

By Type, Diabetes Type, and Distribution Channel

By Type

  • Analogue Insulin
    • Long-acting
    • Fast-acting
    • Premix
  • Traditional Human Insulin
    • Long-acting + Intermediate
    • Short-acting
    • Fast-acting
    • Premix

By Diabetes Type

  • Diabetes 1
  • Diabetes 2

By  Distribution Channel

  • Hospital Pharmacies
  • Retail & Online Pharmacies
  • 2019-2030
  • 2022
  • 2019-2021
  • 81
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X